It looks like taxpayers didn’t just overpay for EpiPens purchased through Medicaid. According to a new report, the Department of Defense has been paying almost full retail price for the expensive emergency allergy treatment. [More]
It looks like taxpayers didn’t just overpay for EpiPens purchased through Medicaid. According to a new report, the Department of Defense has been paying almost full retail price for the expensive emergency allergy treatment. [More]
Part of 